Publication Name	World Journal of Clinical Cases
Manuscript ID	14768
Country

Received	2014-10-23 08:35
Peer-Review Started	2014-10-24 17:20
To Make the First Decision	2014-11-27 12:15
Return for Revision	2014-12-03 10:17
Revised	2014-12-24 09:23
Second Decision	2015-01-14 09:20
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-01-20 16:43
Articles in Press	2015-01-20 16:43
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-03-24 12:15
Publish the Manuscript Online	2015-04-13 15:31

ISSN	2307-8960 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Minireviews
Article Title	Bleeding and clotting in hereditary hemorrhagic telangiectasia
Manuscript Source	Invited Manuscript
All Author List	Christopher Dittus, Michael Streiff and Jack Ansell
Funding Agency and Grant Number
Corresponding Author	Christopher Dittus, DO, MPH, Section of Hematology and Medical Oncology, Boston University Medical Center, FGH Building, First Floor, 820 Harrison Avenue, Boston, MA 02118, United States. cedittus@gmail.com
Key Words	Anticoagulation; Hereditary hemorrhagic telangiectasia; Hemorrhage; Thrombosis; Rivaroxaban; Apixaban; Dabigatran; Warfarin
Core Tip	This article reviews an inherited disorder, hereditary hemorrhagic telangiectasia, in the context of a complicated clinical case. It highlights the problem of balancing the risks of bleeding and thrombosis, and raises the question of whether the new oral anticoagulants might provide safer therapy in such patients who need antithrombotic therapy.
Publish Date	2015-04-13 15:31
Citation	Dittus C, Streiff M, Ansell J. Bleeding and clotting in hereditary hemorrhagic telangiectasia. World J Clin Cases 2015; 3(4): 330-337
URL	http://www.wjgnet.com/2307-8960/full/v3/i4/330.htm
DOI	http://dx.doi.org/10.12998/wjcc.v3.i4.330

Full Article (PDF)	WJCC-3-330.pdf
Full Article (Word)	WJCC-3-330.doc
Manuscript File	14768-Review.docx
Answering Reviewers	14768-Answering reviewers.pdf
Conflict-of-Interest Disclosure Form	14768-Conflict-of-interest statement.pdf
Copyright License Agreement	14768-Copyright assignment.pdf
Peer-review Report	14768-Peer review(s).pdf
Scientific Misconduct Check	14768-CrossCheck.jpg
Scientific Editor Work List	14768-Scientific editor work list.pdf